|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the enforcement and prevention of offenses involving |
|
the manufacture or delivery of controlled substances listed in |
|
Penalty Group 1-B, law enforcement officer safety in handling those |
|
substances, and the manufacture and proper use of opioid |
|
antagonists. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter A, Chapter 411, Government Code, is |
|
amended by adding Section 411.02098 to read as follows: |
|
Sec. 411.02098. FENTANYL OFFENSES ENFORCEMENT TRAINING |
|
PROGRAM. (a) The department, in coordination with local law |
|
enforcement agencies, shall establish and administer a fentanyl |
|
offenses enforcement training program for peace officers employed |
|
by local law enforcement agencies that will prepare the officers |
|
to: |
|
(1) collaborate and cooperate with and assist any law |
|
enforcement agency in the interdiction, investigation, and |
|
prosecution of offenses under Section 481.1123, Health and Safety |
|
Code; and |
|
(2) collaborate and cooperate with and assist district |
|
attorneys, county attorneys, the border prosecution unit, and other |
|
prosecutors in the investigation and prosecution of allegations of |
|
offenses under Section 481.1123, Health and Safety Code. |
|
(b) The training program under Subsection (a) must include: |
|
(1) information on: |
|
(A) criminal activity related to a controlled |
|
substance listed in Penalty Group 1-B under Section 481.1022, |
|
Health and Safety Code, occurring along the Texas-Mexico border, |
|
including manufacture and delivery of those controlled substances |
|
carried out by cartels, transnational gangs, and other groups |
|
engaged in organized criminal activity; and |
|
(B) methods for identifying intrastate criminal |
|
activity associated with the manufacture or delivery of a |
|
controlled substance listed in Penalty Group 1-B under Section |
|
481.1022, Health and Safety Code, and other organized criminal |
|
activity related to those controlled substances; and |
|
(2) best practices for: |
|
(A) the investigation and prosecution of the |
|
criminal activity described by Subdivision (1); |
|
(B) the safest method, as determined by the |
|
Health and Human Services Commission, for handling a controlled |
|
substance listed in Penalty Group 1-B under Section 481.1022, |
|
Health and Safety Code; and |
|
(C) the proper use of an opioid antagonist, as |
|
that term is defined by Section 483.101, Health and Safety Code. |
|
SECTION 2. Subchapter H, Chapter 1701, Occupations Code, is |
|
amended by adding Section 1701.360 to read as follows: |
|
Sec. 1701.360. FENTANYL OFFENSES ENFORCEMENT TRAINING |
|
PROGRAM. The commission may: |
|
(1) recognize, or with the consent of the Department |
|
of Public Safety administer or assist in administering, the |
|
fentanyl offenses enforcement training program established under |
|
Section 411.02098, Government Code, as a continuing education |
|
program for officers; and |
|
(2) credit an officer who successfully completes the |
|
program described by Subdivision (1) with the appropriate number of |
|
continuing education hours. |
|
SECTION 3. (a) In this section, "opioid antagonist" has |
|
the meaning assigned by Section 483.101, Health and Safety Code. |
|
(b) The lethal opioid poisoning prevention task force is |
|
established under this section to: |
|
(1) compile data on criminal activity in the |
|
Texas-Mexico border region related to the manufacture or delivery |
|
of a controlled substance listed in Penalty Group 1-B under Section |
|
481.1022, Health and Safety Code; |
|
(2) develop best practices for: |
|
(A) the investigation, interdiction, and |
|
prosecution of criminal activity that constitutes an offense under |
|
Section 481.1123, Health and Safety Code; |
|
(B) the safe handling of a controlled substance |
|
listed in Penalty Group 1-B under Section 481.1022, Health and |
|
Safety Code; and |
|
(C) the proper use of an opioid antagonist; and |
|
(3) study methods to incentivize manufacturers of |
|
opioid antagonists to increase production, particularly for opioid |
|
antagonists to be used by law enforcement agencies of this state. |
|
(c) The governor shall appoint to the task force: |
|
(1) two members representing the Department of Public |
|
Safety; |
|
(2) two members representing the Health and Human |
|
Services Commission; and |
|
(3) two members representing the Texas Commission on |
|
Law Enforcement. |
|
(d) Not later than six months after the date the governor |
|
appoints members to the task force, the task force shall submit to |
|
the governor and the director of the Department of Public Safety a |
|
report containing the data and best practices described by |
|
Subsections (b)(1) and (2) of this section. |
|
(e) Not later than December 1, 2026, the task force shall |
|
submit a report to the legislature containing its findings |
|
regarding the methods described by Subsection (b)(3) of this |
|
section, including proposed legislation to increase the |
|
manufacturing production of opioid antagonists. |
|
(f) The task force established under this section is |
|
abolished and this section expires January 1, 2027. |
|
SECTION 4. As soon as practicable after the effective date |
|
of this Act, the governor shall appoint the members of the task |
|
force established by Section 3 of this Act. |
|
SECTION 5. This Act takes effect immediately if it receives |
|
a vote of two-thirds of all the members elected to each house, as |
|
provided by Section 39, Article III, Texas Constitution. If this |
|
Act does not receive the vote necessary for immediate effect, this |
|
Act takes effect September 1, 2025. |